CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Vanda Pharmaceuticals Inc. v. Apotex Inc.

1:23-cv-00153

Overview

Case Number 1:23-cv-00153
Filing Date 2023-02-10
Status Litigation filed
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Plaintiff

Parties

Defendant

Apotex Corp. Operating Company

Represented By

7 Attorneys Listed

Madison H. McNulty

Email: mmcnulty@cozen.com

Michael C. Pomeroy

Email: mpomeroy@cozen.com

William B. Coblentz

Email: wcoblentz@cozen.com

Kerry B. McTigue

Email: kmctigue@cozen.com

Keri L. Schaubert

Email: kschaubert@cozen.com

Aaron S. Lukas

Email: alukas@cozen.com

Kaan Ekiner

Cozen O'Connor

Tel: +1 (302) 295-2046

Cozen O'Connor, 1201 North Market Street

Apotex Inc. Operating Company

Represented By

7 Attorneys Listed

Madison H. McNulty

Email: mmcnulty@cozen.com

Michael C. Pomeroy

Email: mpomeroy@cozen.com

William B. Coblentz

Email: wcoblentz@cozen.com

Kerry B. McTigue

Email: kmctigue@cozen.com

Keri L. Schaubert

Email: kschaubert@cozen.com

Aaron S. Lukas

Email: alukas@cozen.com

Kaan Ekiner

Cozen O'Connor

Tel: +1 (302) 295-2046

Cozen O'Connor, 1201 North Market Street

Plaintiff

Vanda Pharmaceuticals Inc. Operating Company

Represented By

9 Attorneys Listed

Samoneh Kadivar Schickel

Email: sschickel@mcdermottlaw.com

Mary H. Schnoor

Email: mschnoor@mcdermottlaw.com

Sarah P. Hogarth

Email: shogarth@mcdermottlaw.com

Paul W. Hughes

Email: phughes@mwe.com

Christopher M. Bruno

Email: chris@ipfdalaw.com

April E. Weisbruch

Email: aweisbruch@mwe.com

Alexandra M. Joyce

McCarter & English, LLP

Tel: +1 (302) 984-6392
Fax: +1 (302) 450-4235

Renaissance Centre, 405 N. King Street, 8th Floor

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

Ethan Haller Townsend

McDermott Will & Schulte LLP

Tel: +1 (302) 485-3900

The Brandywine Building, 1000 N. West Street

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 19 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (19): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US11285129
Treatment of circadian rhythm disorders
Filed: 2021-07-06
Issued: 2022-03-29
Active (14.6 yrs remaining)
Expires: 2041-07-06
US11918556
Treatment of circadian rhythm disorders
Filed: 2022-02-15
Issued: 2024-03-05
Active (6.4 yrs remaining)
Expires: 2033-04-07

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

93

Dispositive

34

Granted

4

Denied

1

Pending / Review

79

Motions by Category

Motion for Preliminary Injunction / TRO 6 Motion to Transfer Venue (28 U.S.C. § 1404) 3 Procedural / Extension Motion 36 Motion to Dismiss (FRCP 12(b)(6)) 8 Motion to Strike / Sanctions 5 Claim Construction / Markman Filing 18 Motion for Summary Judgment (Infringement) 12 Motion for Summary Judgment (Rule 56) 5

Key Dispositive Motions & Rulings

Motion for Summary Judgment (Infringement) Pending / Under Review
ORAL ORDER: At the conclusion of the October 1, 2026 teleconference, the Court ordered the parties to provide letters to the Court on specified topics. In addit...
Entry #319 • 2026-10-01 Document →
Motion for Summary Judgment (Infringement) Pending / Under Review
MEMORANDUM OPINION re Defendants' Motion for Summary Judgment #1: Non-Infringement. (No. 23-152, D.I. 297; No. 23-153, D.I. 250). Signed by Judge Jennifer L. Ha...
Entry #314 • 2026-09-24 Document →
Motion for Summary Judgment (Infringement) Granted
ORDER re (314 in 1:23-cv-00153-JLH, 387 in 1:23-cv-00152-JLH) Memorandum Opinion: IT IS HEREBY ORDERED that the parties shall meet and confer as soon as practic...
Entry #315 • 2026-09-24 Document →
Motion for Summary Judgment (Rule 56) Denied
ORDER: IT IS HEREBY ORDERED that Defendants' Motion for Summary Judgment #2: The Asserted Patents Are Entitled to a Priority Date No Earlier Than July 6, 2021 (...
Entry #316 • 2026-09-24 Document →
Motion for Summary Judgment (Infringement) Pending / Under Review
[SEALED] SUPPLEMENTAL RESPONSE BRIEF in Opposition to 297 Defendants' Motion for Summary Judgment of Non-Infringement, by Vanda Pharmaceuticals Inc. (Attachment...
Entry #310 • 2026-07-16 Document →
Motion for Summary Judgment (Infringement) Pending / Under Review
REDACTED VERSION of 308 SUPPLEMENTAL BRIEF in Support re 250 Motion for Summary Judgment of Non-Infringement, by Apotex Corp., Apotex Inc. (Attachments: # 1 Exh...
Entry #309 • 2026-07-08 Document →

Docket Entries

(433 total)
Pleading / Complaint

COMPLAINT against APOTEX CORP., APOTEX INC. ( Filing and Admin fee $ 402 receipt number ANJDC-13921541) with JURY DEMAND, Related Case Selected, filed by VANDA PHARMACEUTICALS INC.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet, # 3 Certification Pursuant to L. Civ. R. 11.2)(QUINN, JUSTIN) [Transferred from New Jersey on 2/10/2023.] (Entered: 12/27/2022)

Entry #1 • 2022-12-27
1
Pleading / Complaint

COMPLAINT against APOTEX CORP., APOTEX INC. ( Filing and Admin fee $ 402 receipt number ANJDC-13921541) with JURY DEMAND, Related Case Selected, filed by VANDA PHARMACEUTICALS INC.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet, # 3 Certification Pursuant to L. Civ. R. 11.2)(QUINN, JUSTIN) [Transferred from New Jersey on 2/10/2023.] (Entered: 12/27/2022)

Entry #1 • 2022-12-27
2
Pleading / Complaint

COMPLAINT against APOTEX CORP., APOTEX INC. ( Filing and Admin fee $ 402 receipt number ANJDC-13921541) with JURY DEMAND, Related Case Selected, filed by VANDA PHARMACEUTICALS INC.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet, # 3 Certification Pursuant to L. Civ. R. 11.2)(QUINN, JUSTIN) [Transferred from New Jersey on 2/10/2023.] (Entered: 12/27/2022)

Entry #1 • 2022-12-27
2
Pleading / Complaint

COMPLAINT against APOTEX CORP., APOTEX INC. ( Filing and Admin fee $ 402 receipt number ANJDC-13921541) with JURY DEMAND, Related Case Selected, filed by VANDA PHARMACEUTICALS INC.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet, # 3 Certification Pursuant to L. Civ. R. 11.2)(QUINN, JUSTIN) [Transferred from New Jersey on 2/10/2023.] (Entered: 12/27/2022)

Entry #1 • 2022-12-27
2

Corporate Disclosure Statement by VANDA PHARMACEUTICALS INC.. (QUINN, JUSTIN) [Transferred from New Jersey on 2/10/2023.] (Entered: 12/27/2022)

Entry #2 • 2022-12-27
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc